Copy in clipboard...
Iranian official ensures continuous supply of medicines for thalassemia patients
Heidar Mohammadi highlighted the collaboration with thalassemia associations and blood specialists in improving drug provision for these patients, mentioning that all thalassemia drugs in the country are domestically produced, IRNA wrote.
He also addressed the increase in imported medications for thalassemia patients in 2023 compared to 2022, expressing hope for continued support from the Central Bank of Iran and currency reserves to meet the needs of these patients this year.
Mohammadi emphasized that there are no restrictions on supplying drugs for special patients, mentioning challenges posed by international sanctions hindering some foreign companies from selling medicines to Iran.
He assured that efforts are being made to ensure access to both locally produced and imported medications for those sensitive to domestic drugs, reflecting the organization’s commitment to meeting the needs of patients.